Back

Guggenheim Securities Maintains Buy on Johnson & Johnson With $227 Target

Analyst Vamil Divan cites stronger-than-expected 2026 guidance from the pharmaceutical giant as the basis for the bullish outlook.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Price Target: An analyst’s projection of a security’s future price, used to guide investment decisions.
  • Buy Rating: A recommendation from an analyst indicating the stock is expected to outperform the market or peer group.